Skip to main content

Table 2 Patient characteristicsa

From: Clara cell protein in bronchoalveolar lavage fluid: a predictor of ventilator-associated pneumonia?

Parameter

VAP

Non-VAP

P value

Number of patients

79

117

 

Mean age in years (range)

60 (19-84)

58 (18-87)

0.445

Male:female ratio

1.6:1

1.7:1

0.887

Mortality rate (%)

44

36

0.324

Median hospital stay in days (range)

47 (7-540)

47 (6-297)

0.289

Median ICU stay in days (range)

43 (6-484)

46 (1-291)

0.454

Median days of intubation (range)

8 (1-172)

8 (1-198)

0.289

Reason for admission, number of patients (%)

   

   Cardiac

6 (7.6)

12 (10.3)

 

   Pulmonary

14 (17.8)

27 (23.1)

 

   Trauma

14 (17.8)

15 (12.8)

 

   Surgery

17 (21.5)

15 (12.8)

 

   Neurological

10 (12.6)

6 (5.1)

 

   Malignancy

5 (6.3)

9 (7.7)

 

   Vascular surgery

6 (7.6)

19 (16.2)

 

   Other

7 (8.3)

14 (12.0)

 

Median Clara cell protein concentration in ng/mL (range)

3,019 (282-65,546)

2,504 (62-30,240)

0.03

  1. aVAP, ventilator-associated pneumonia; ICU, intensive care unit.